These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29370100)

  • 21. pH-responsive polymeric micelles self-assembled from benzoic-imine-containing alkyl-modified PEGylated chitosan for delivery of amphiphilic drugs.
    Hsu CW; Hsieh MH; Xiao MC; Chou YH; Wang TH; Chiang WH
    Int J Biol Macromol; 2020 Nov; 163():1106-1116. PubMed ID: 32679318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release behavior of amoxicillin from glycol chitosan superporous hydrogels.
    Park J; Kim D
    J Biomater Sci Polym Ed; 2009; 20(5-6):853-62. PubMed ID: 19323894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosylated-Chitosan Derivatives: A Systematic Review.
    Sacco P; Cok M; Scognamiglio F; Pizzolitto C; Vecchies F; Marfoglia A; Marsich E; Donati I
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32230971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice.
    Liu Z; Lv D; Liu S; Gong J; Wang D; Xiong M; Chen X; Xiang R; Tan X
    PLoS One; 2013; 8(4):e60190. PubMed ID: 23577091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of pH sensitive comb-shaped chitosan material for the controlled release of coenzyme A.
    Guo B; Yuan J; Gao Q
    J Mater Sci Mater Med; 2007 May; 18(5):753-7. PubMed ID: 17136607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan as a novel nasal delivery system for vaccines.
    Illum L; Jabbal-Gill I; Hinchcliffe M; Fisher AN; Davis SS
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):81-96. PubMed ID: 11516781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review on chitosan and its nanocomposites in drug delivery.
    Ali A; Ahmed S
    Int J Biol Macromol; 2018 Apr; 109():273-286. PubMed ID: 29248555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of Chitosan Derivatives as Adjuvant for Nanoparticles Based Vaccines.
    Narayanan RR; Maanvizhi S
    Infect Disord Drug Targets; 2023; 23(3):e220922209066. PubMed ID: 36154588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
    Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination.
    Heuking S; Iannitelli A; Di Stefano A; Borchard G
    Int J Pharm; 2009 Nov; 381(2):97-105. PubMed ID: 19782879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan-based nanomaterials: a state-of-the-art review.
    Shukla SK; Mishra AK; Arotiba OA; Mamba BB
    Int J Biol Macromol; 2013 Aug; 59():46-58. PubMed ID: 23608103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications.
    Alves NM; Mano JF
    Int J Biol Macromol; 2008 Dec; 43(5):401-14. PubMed ID: 18838086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.
    Shim S; Yoo HS
    Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positively charged amphiphilic chitosan derivative for the transscleral delivery of rapamycin.
    Elsaid N; Jackson TL; Gunic M; Somavarapu S
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8105-11. PubMed ID: 23049091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs.
    Almeida A; Araújo M; Novoa-Carballal R; Andrade F; Gonçalves H; Reis RL; Lúcio M; Schwartz S; Sarmento B
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110920. PubMed ID: 32409071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan and Its Derivatives - Biomaterials with Diverse Biological Activity for Manifold Applications.
    Paul P; Kolesinska B; Sujka W
    Mini Rev Med Chem; 2019; 19(9):737-750. PubMed ID: 30648508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Applications of chitosan and its derivatives in pharmaceutical industry of Chinese medicine].
    Wang LH; Wu GL; Cheng YY
    Zhongguo Zhong Yao Za Zhi; 2004 Apr; 29(4):289-92. PubMed ID: 15706858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Particulate delivery systems for vaccines.
    Bramwell VW; Perrie Y
    Crit Rev Ther Drug Carrier Syst; 2005; 22(2):151-214. PubMed ID: 15862111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.